Cargando...
Industry perspectives on biomarker qualification
Biomarkers have the potential to expedite drug development, increase patient safety, and optimize clinical response. Yet few have achieved regulatory qualification. A survey was conducted to clarify industry's perspective on biomarker qualification and identify the most promising biomarkers for...
Guardado en:
| Publicado en: | Clin Pharmacol Ther |
|---|---|
| Autores principales: | , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
John Wiley and Sons Inc.
2015
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5065241/ https://ncbi.nlm.nih.gov/pubmed/26378777 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cpt.264 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|